News - Valeant Pharmaceuticals, Obagi Medical Products

Filter

Popular Filters

Briefs: Bidding war for Obagi escalates, as Valeant ups offer; AstraZeneca plans to sue Actavis

03-04-2013

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) today (April 3) announced…

ActavisAstraZenecaDermatologicalsGenericsLegalMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalPulmicort RespulesRespiratory and PulmonaryValeant Pharmaceuticals

Merz Pharma enters bidding war for Obagi; Ferro sells pharma unit

02-04-2013

German family-owned firm Merz Pharma has written to the board of director of Obagi Medical Products outlining…

Ferro GroupGenericsMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPfanstiehl LaboratoriesPharmaceuticalValeant Pharmaceuticals

Valeant to acquire Obagi Medical for around $344 million

20-03-2013

Canada-based Valeant Pharmaceuticals International (TSX: VRX) is on the acquisition trail again, announcing…

DermatologicalsMergers & AcquisitionsObagi Medical ProductsPharmaceuticalValeant Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top